EDGAR Filing Documents for 0001176256-12-000130

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001176256-12-000130

Filing Date

2012-03-01

Accepted

2012-03-01 16:05:30

Documents

Period of Report

2012-03-01

Document Format Files

Seq	Description	Document	Type	Size
1	REPORT OF FOREIGN ISSUER FOR THE MONTH OF MARCH, 2012	120301nymox6knr.htm	6-K	4883
2	NEWS RELEASE DATE MARCH 1, 2012	exhibit99-1.htm	EX-99.1	5492
3		exhibit99-1x1x1.jpg	GRAPHIC	6450
	Complete submission text file	0001176256-12-000130.txt		20433

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 5143323222

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 12657758
SIC: 2835 In Vitro & In Vivo Diagnostic Substances